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α-synuclein-mediated autophagy inhibition
in PC12 cells
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Abstract
Background: Aberrant α-synuclein aggregation due to the deficiency of ubiquitin-proteasome or of autophagy
characterizes the parkinson disease (PD). High mobility group box 1 (HMGB1) is a novel stress sensor to mediate the
persistent neuro-inflammation and the consequent progressive neurodegeneration, via controlling the cellular
autophagy/apoptosis checkpoint during inflammation. Moreover, HMGB1 has been recently indicated to involve in the
autophagic degradation of α-synuclein.
Methods: In the current study, we investigated the influence of the overexpressed α-synuclein of wild type (wt)
or mutant type (A53T and A30P, mt) on the cytosolic levels of HMGB1 and Beclin1 and on the starvation-induced
autophagy in pheochromocytoma PC12 cells. And then we explored the overexpression of HMGB1 or of Beclin1
on the α-synuclein degradation and on the autophagy in the α-synuclein-overexpressed PC12 cells.
Results: It was demonstrated that α-synuclein overexpression inhibited the trans-location of HMGB1 from nucleus to
cytosol and reduced the cytosolic level of Beclin1 in PC12 cells, and inhibited the starvation-induced autophagy via
downregulating autophagy-associated markers and via reducing the autophagic vesicles in PC12 cells under
starvation. On the other side, the intracellular promotion of either HMGB1 or Beclin1 upregulated the α-synuclein
degradation and ameliorated the α-synuclein-mediated autophagy reduction in PC12 cells. However, the exogenous
HMGB1 treatment exerted no such regulation in PC12 cells.
Conclusion: In summary, our study confirmed the positive regulation by HMGB1 and Beclin1 on the α-synuclein
degradation and on the starvation-induced autophagy in PC12 cells, implying both markers as prominent targets
to promote the α-synuclein degradation.
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Background
Aberrant α-synuclein aggregation and the followed degen-
eration of dopaminergic cells [1–4] characterize the par-
kinson disease (PD). The deficient protein degradation
pathways such as ubiquitin-proteasome system (UPS) and
autophagy lysosomal pathway (ALP) have been recognized
to contribute to the scanty degradation of wild-type (WT)
or mutant-type (MT, A53T and A30P) α-synuclein [5, 6].
Moreover, autophagy is the only clearance pathway for the
aggregated α-syn [7, 8]. And the both macromolecular
complexes, mammalian target of rapamycin (mTOR)-
Unc-51 like autophagy activating kinase 1 (ULK1) com-
plex and the Beclin 1-Phosphatidylinositol 3-kinase
catalytic subunit type 3 (PIK3C3) complex [9] are im-
portant for α-synuclein degradation [10].
Recently, multiple molecules have been characterized
to regulate autophagy via the mTOR-ULK1 or PIK3C3
pathway. Amino acid starvation stimulates phosphoryl-
ation of ULK1 by protein phosphatase 2A to form
PP2A-B55α complex and induces the ULK1-dependent
autophagy [11, 12]. The transcriptional regulation of
Annexin A2 also promotes the starvation-induced
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autophagy, via regulating autophagosome formation by
enabling appropriate Autophagy-related protein (ATG)
9A trafficking from endosomes to autophagosomes [13].
Moreover, various markers have been confirmed to regu-
late autophagy through the PIK3C3 pathway. Dapper1
promotes autophagy by enhancing the Beclin1- vacuolar
protein sorting 34 (VPS34)-Atg14L complex formation
[14]. Interferon-alpha-2b induces autophagy in hepato-
cellular carcinoma cells via stimulating Beclin1 pathway
[15]. Rho-associated, coiled-coil containing protein
kinase 1 (ROCK1) promotes autophagy by binding and
phosphorylating Beclin1 at Thr119 under metabolic
stress [16]. However, Macrophage stimulating 1 (Mst1)
inhibits autophagy by promoting the interaction be-
tween Beclin1 and Bcl-2 [17]. And Smad2 binds to the
Beclin1 promoter region, transcriptionally regulates au-
tophagy via regulating beclin1 expression [18].
High mobility group box 1 (HMGB1) is a stress sen-
sor that plays a critical role in various physiological and
pathological processes including cell development, differ-
entiation, inflammation, metabolism and death [19]. In-
creasing evidence demonstrates that HMGB1-dependent
autophagy promotes chemotherapy resistance [20], sus-
tains tumor metabolism [21], protects against endotox-
emia [22] and involves in other pathological processes
[23, 24]. Inflammation has also been recognized to
involve in PD [25–27]. Sustained inflammatory process
and the activated microglia might drive the progressive
degeneration of dopamine neurons in PD [28]. Moreover,
the cytoplasmic HMGB1 has been indicated to control the
cellular autophagy/apoptosis checkpoint during inflamma-
tion [29]. HMGB1 was demonstrated to mediate the
persistent neuroinflammation and consequent progressive
neurodegeneration, via stimulating the production of
multiple inflammatory and neurotoxic factors [30]. In
addition, HMGB1 has been recently indicated to involve
in the autophagy inhibition caused by α-synuclein overex-
pression [31], implying a direct role in modulating au-
tophagic degradation of α-synuclein.
In current study, we investigated the regulation of α-
synuclein overexpression on the trans-location or the
expression of HMGB1 and Beclin1, and on the starvation-
induced autophagy in pheochromocytoma PC12 cells.
And then we explored the overexpression of HMGB1 or
Beclin1 on the α-synuclein degradation and on the au-
tophagy in the α-synuclein-overexpressed PC12 cells. This
study confirmed the positive regulation by endogenous
HMGB1 on the autophagy-mediated α-synuclein degrad-
ation in PC12 cells.
Methods
Construction of PC12 (Synwt) and PC12 (Synmt) cells
Rattus norvegicus pheochromocytoma PC12 cell line
was purchased from American Type Culture Collection
(ATCC) (Rockville, MD, USA) and was cultured in
RPMI-1640 medium (GIBCO, Rockville, MD, USA) sup-
plemented with 10 % (2 % for maintaining) fetal bovine
serum (FBS) (Hyclone, Pittsburgh, PA, USA) and with
100 U/mL penicillin and 100 mg/mL streptomycin
(CSPC Pharmaceutical Group Limited, China). Cells
were cultured at 37 °C in a humidified incubator with
5 % CO2. To construct an α-synuclein-overexpressed
PC12 cell line, the wild-type (wt) (NM_019169.2), mutant-
type (mt, A53T and A30P) α-synuclein coding sequence,
or the Enhanced Green Fluorescence Protein (EGFP) cod-
ing sequence (as control) was amplified and cloned into
the pcDNA3.1(+) vector (Invitrogen, Carlsbad, CA, USA).
Then we transfected the α-Syn(wt)-pcDNA3.1(+), α-
Syn(mt)-pcDNA3.1(+) or EGFP-pcDNA3.1(+) plasmid
into the 85 % confluent PC12 cells with lipofectamine
2000 (Invitrogen, Carlsbad, CA, USA). After the transfec-
tion for 24 hours, cells were updated with the RPMI-1640
medium which were supplemented with 10 % FBS and
with 1.2 mg/ml G418 (Life Technologies, Grand Island,
NY, USA) to select the cell clone overexpressing wt or mt
α-synuclein or EGFP. And the selected PC12 (Synwt),
PC12 (Synmt) and PC12 (Con) cell clones were cultured in
RPMI-1640 medium+ 10 % FBS supplemented with
0.8 mg/ml G418. For the starvation treatment, PC12
(Synwt), PC12 (Synmt) and PC12 (Con) cells were inocu-
lated with FBS-free RPMI-1640 medium at 37 °C in a
humidified chamber with 5 % CO2.
Overexpression of HMGB1 or Beclin 1 in PC12 (Synwt)
or PC12 (Synmt) cells
To promote the HMGB1 level in PC12 (Synwt) or PC12
(Synmt) cells, the coding sequence of HMGB1 or the cod-
ing sequence of Red Fluorescence Protein (RFP) was
cloned into the pcDNA3.1(+) vector. And 5 μg/mL (to
guarantee more than 90 % cells to be transfected)
HMGB1-pcDNA3.1(+) or RFP-pcDNA3.1(+) plasmid was
transfected into 105 per well 85 % confluent PC12 (Synwt)
or PC12 (Synmt) cells. To upregulate the Beclin1 level in
PC12 cells, Beclin1 or the coding sequence of Chloram-
phenicol acetyl transferase(CAT) was amplified and was
cloned into the pLenti 6/TR vector (Invitrogen, Carlsbad,
CA, USA). Recombinant pLenti-Beclin1 (LV-Beclin1) or
pLenti-CAT virus of (LV-Con) was produced by cotrans-
fecting 293 T cells with pLenti-Beclin1 or pLenti-CAT and
ViraSafe™ Lentiviral Packaging System (Cell Biolabs, San
Diego, CA, USA). PC12 (Synwt) or PC12 (Synmt) cells were
infected with LV-Beclin1 or LV-Con virus with 1 Multipli-
city of infection (MOI) for 12 or 24 hours.
mRNA isolation and real-time PCR analysis of
α-synuclein mRNA
mRNA samples from OVCAR-3 cells were prepared
with Kit for mRNA Isolation and Purification (Clontech,
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Palo Alto, CA, USA), and reverse transcription (RT)
was performed with M-MLV Reverse Transcriptase
(Promega, Madison, WI, USA) as following: 42 °C for
5 min and 95 °C for 10 sec for the reverse transcription.
And the real-time PCR assay was performed at 95 °C for
5 sec and 60 °C for 20 sec for the PCR reaction, with 40 -
cycles. The primer sequences for α-synuclein were as fol-
lowing: forward primer, 5’- CGT CCT CTA TGT AGG
TTC CA -3’, reverse primer: 5’- GCC ACT GTT GTC
ACT CCA TG -3’. The primer sequences for β-actin were
as following: forward primer, 5’- GTA CCC TGG CAT
TGC CGA CA -3’, reverse primer: 5’- GGA CTC GTC
ATA CTC CTG CTT GCT -3’. Relative α-synuclein
mRNA level was normalized to internal control β-actin,
with the ΔΔCt method [32].
Western blotting assay
PC12, PC12 (Con), PC12 (Synwt) or PC12 (Synmt) cells
were homogenized with an ice-cold NE-PER Nuclear
and Cytoplasmic Extraction Reagents Kit (Pierce,
Rockford, IL, USA), the nuclear and the cytoplasmic
proteins were isolated according to the product’s man-
ual. Each protein sample was supplemented with a
protease Inhibitor Cocktail (Abcam, Cambridge, UK)
and was stored at -80 °C before use. The western blot-
ting assay was performed with the rabbit polyclone
antibody against α-synuclein (Abcam, Cambridge,
UK), against HMGB1(Abcam, Cambridge, UK), against
Beclin1 (Cell Signaling Technology Inc., Danvers, MA,
USA), against LC3 (Pierce, Rockford, IL, USA), Atg 7
(Sigma-Aldrich, St. Louis, MO, USA), against mTOR
(Abcam, Cambridge, UK), against LMNB1 (Pierce,
Rockford, IL, USA) or against β-actin (Sinobio, Beijing,
China), and with horseradish peroxidase-linked secondary
antibodies (Jackson ImmunoResearch, West Grove, PA,
USA). The specific binding band was scanned and quanti-
fied according to the band density.
Quantitative EGFP-LC3 analysis and electron microscopy
1 × 105 cells/well PC12, PC12 (Con), PC12 (Synwt) or
PC12 (Synmt) cells were transfected with 2 μg EGFP-
LC3 reporter plasmid, pcDNA3.1-EGFP-LC3, with Lipo-
fectamine 2000 (Invitrogen, Carlsbad, CA, USA) for a
24 hour’s incubation to quantify the EGFP-positive au-
tophagic vesicles which were promoted by various treat-
ments. Then the EGFP-positive vesicles were visualized
under fluorescence microscopy (JEM1230, Japan).
Statistical evaluations
Quantitative data was presented as mean ± SE and was
analyzed for a significant difference with the Student’s
t test or one way ANOVA test. A p value less than
0.05 was considered to be statistically significant.
Results
α-synuclein overexpression inhibits the trans-location of
HMGB1 and the expression of Beclin1 in PC12 cells
To investigate the regulation of α-synuclein overexpres-
sion on the trans-location or the level of HMGB1 and
Beclin1, and on the starvation-induced autophagy in
pheochromocytoma PC12 cells, we constructed the
PC12 cell overexpressing WT α-synuclein, PC12 (Synwt),
or the PC12 cell overexpressing MT (A53T and A30P)
α-synuclein, PC12 (Synmt), with PC12 (Con), which
overexpressed enhanced green fluorescent protein
(EGFP), as control. As shown in Fig. 1a, the mRNA level
of α-synuclein was significantly higher in both PC12
(Synwt) and PC12 (Synmt) cells, compared with the PC12
(Con) or blank PC12 cells (either p < 0.001 for PC12
(Synwt) or PC12 (Synmt) cells). And the protein level of
α-synuclein was confirmed by the western blot analysis
in the PC12 (Synwt) or PC12 (Synmt) cells (p < 0.001 re-
spectively, Fig. 1b). And then we investigated the influ-
ence of α-synuclein overexpression on the Beclin1 level
and the trans-location of HMGB1 from nucleus to
cytosol. Western blotting (Fig. 1c) demonstrated that
the cytosolic HMGB1 was markedly upregulated,
whereas was significantly downregulated in nucleus in
either PC12 (Synwt) or PC12 (Synmt) cells (p < 0.05 re-
spectively, Fig. 1c). In addition the cytoplasmic Beclin1
was also examined with western blot analysis. It was in-
dicated that the Beclin level was significantly downregu-
lated in both PC12 (Synwt) and PC12 (Synmt) cells (p < 0.01
respectively, Fig. 1d). Thus, we confirmed the promotion to
the trans-location of HMGB1 from nucleus to cytosol, and
to the cytoplasmic level of Beclin1 in PC12 cells.
α-synuclein overexpression inhibits autophagy in
PC12 cells
We then examined the regulation of the overexpressed
α-synuclein on the autophagy in PC12 cells. The autoph-
agy induction in PC12, PC12 (Con), PC12 (Synwt) or
PC12 (Synmt) cells subject to starvation was examined
with western blotting assay and the EGFP-LC3 reporter
assay. Western blotting results (Fig. 2a) demonstrated
that the conversion of LC3-I to LC3-II was markedly
lower in either PC12 (Synwt) or PC12 (Synmt) cells, com-
pared to the normal PC12 or the PC12 (Con) cells (p <
0.01 respectively, Fig. 2b). And such reduced autophagy
was also confirmed by the reduced level of Atg7 and in-
creased level of mTOR in either PC12 (Synwt) or PC12
(Synmt) cells (p < 0.01 respectively, Fig. 2b). Moreover,
the EGFP-LC3 reporter assay also demonstrated that
there were less GFP-positive autophagic puncta in either
PC12 cells. Taken together, the α-synuclein overexpres-
sion with wild or mutant type inhibits the starvation-
stimulated autophagy in PC12 cells.
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HMGB1 promotes autophagy and α-synuclein degradation
in the α-synuclein-overexpressed PC12 cells
To investigate the role of HMGB1 on the autophagic
degradation of α-synuclein, we overepressed HMGB1
in both PC12 (Synwt) and PC12 (Synmt) cells with the
gain-of-function strategy, and then re-evaluated the
starvation-induced autophagy in both cell lines. Western
blotting assay (Fig. 3a) demonstrated that the transfection
with HMGB1-pcDNA3.1(+) (pc-HMGB1) dramatically
upregulated the HMGB1 level in both PC12 (Synwt)
(Fig. 3b) and PC12 (Synmt) (Fig. 3c) cells at 12 or 24 hour
post transfection (H.P.T.) (p < 0.01 or p < 0.001), and time-
dependently (p < 0.05). However, the α-Synuclain level was
markedly downregulated in both PC12 (Synwt) (Fig. 3d) and
PC12 (Synmt) (Fig. 3e) cells (p < 0.05 respectively). More-
over, the EGFP-LC3 reporter assay (Fig. 3f) demonstrated
Fig. 1 Overexpression of α-synuclein with wild type (wt) or mutant type (mt) reduces cytosolic HMGB1 and Beclin1 in PC12 cells. a and b:
mRNA (a) and protein (b) levels of α-synuclein in the PC12 cell overexpressing wt α-synuclein, PC12 (Synwt), in the PC12 cell overexpressing
mt (A53T and A30P) α-synuclein, PC12 (Synmt), in the PC12 cell overexpressing Enhanced Green Fluorescence Protein (EGFP), PC12 (Con), or in
the blank P12 cells, the protein level of α-synuclein was examined by western blot analysis; c: Western blot analysis of HMGB1 (in cytosol and
in nucleus) and Beclin1 (in cytosol) in PC12, PC12 (Con), PC12 (Synwt) or PC12 (Synmt) cells; d: Relative HMGB1 level to β-actin in cytosol or to
Lamin B(LMNB1) in the nucleus of PC12, PC12 (Con), PC12 (Synwt) or PC12 (Synmt) cells; e: Relative Beclin1 level to β-actin in the cytosol of
PC12, PC12 (Con), PC12 (Synwt) or PC12 (Synmt) cells; Each result was averaged for triple independent experiments. Statistical significance was
presented as * p < 0.05, ** p < 0.01, *** p < 0.001, ns: no significance
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that the overexpressed HMGB1 promoted more autophagic
vesicles in either PC12 (Synwt) or PC12 (Synmt) cells which
were subject to starvation. Therefore, HMGB1 promotes α-
synuclein degradation and ameliorates the α-synuclein-
mediated autophagy reduction in PC12 cells.
In addition, we also investigated the influence of ex-
ogenous HMGB1 treatment on the starvation-induced
autophagy in PC12 cells. Western blotting assay (Fig. 4a)
demonstrated that the treatment with 0.2 to 1 μg/mL
HMGB1 did not significantly regulate the conversion of
LC3-I to LC3-II (Fig. 4b) and the expression of Atg 7
(Fig. 4c) and mTOR (Fig. 4d). Therefore, the exogenous
HMGB1 exerts no regulation on the starvation-induced
autophagy in PC12 cells.
Beclin1 overexpression promotes autophagy and
α-synuclein degradation in the α-synuclein-overexpressed
PC12 cells
Given the high importance of Beclin1-dependent au-
tophagy in the α-synuclein degradation [10, 12], we then
Fig. 2 Levels of autophagy-associated markers and autophagic vesicles induced by starvation in the PC12, PC12 (Con), PC12 (Synwt) or PC12 (Synmt)
cells. a: Western blotting assay of LC3-I, LC3-II, Atg 7 and mTOR in the PC12, PC12 (Con), PC12 (Synwt) or PC12 (Synmt) cells post an incubation at 37 °C
in FBS-free medium for 24 hours; b: Ratio of LC3-II to LC3-I in the starvation-treated cell lines; c: Relative level of Atg 7 and mTOR levels to β-actin in
each cell line post the starvation treatment; d and e: Imaging (d) and counting (e) of EGFP-positive autophagic vesicles in the cytosol of
starvation-treated PC12, PC12 (Con), PC12 (Synwt) or PC12 (Synmt) cells which were transfected with pCDNA3.1-EGFP-LC3 plasmid for another
24 hours; Data was averaged for triple independent results. * p < 0.05, ** p < 0.01, ns: no significance
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investigated the influence of Beclin1 overexpression on
the α-synuclein degradation and the starvation-induced
autophagy in both PC12 (Synwt) and PC12 (Synmt) cells.
As shown in Fig. 5a, the lentivirus-mediated Beclin1
overexpression in protein level was significant in both
cell lines (Fig. 5b and c) at either 12 or 24 H.P.I. (p <
0.001 respectively) with 1 multiplicity of infection (MOI)
with the Beclin1-lentivirus (LV-Beclin1). And the α-
synuclein level was markedly reduced at 12 or 24 H.P.I.
in the LV-Beclin1-infected PC12 (Synwt) (either p < 0.05
for 12 or 24 H.P.I., Fig. 5d) or PC12 (Synmt) cells (p <
0.01 or p < 0.001 for 12 or 24 H.P.I., Fig. 5e). In addition,
Fig. 3 HMGB1 upregulation inhibits α-synuclein accumulation and ameliorates the α-synuclein-inhibited autophagy in PC12 (Synwt) and PC12
(Synmt) cells. a: Western blot analysis of HMGB1 and α-synuclein in PC12 (Synwt) and PC12 (Synmt) cells, which were transfected with HMGB1-pcDNA3.1(+)
or RFP-pcDNA3.1(+) plasmid for 12 or 24 hours; b and c: Ratio of HMGB1 to β-actin in PC12 (Synwt) and PC12 (Synmt) cells with or without
HMGB1 promoted; d and e: Ratio of α-synuclein to β-actin in PC12 (Synwt) and PC12 (Synmt) cells, with or without HMGB1 promoted; f and g: Imaging
(f) and counting (g) of EGFP-positive autophagic vesicles in the cytosol of starvation-treated PC12 (Synwt) or PC12 (Synmt), with or without
HMGB1 promoted. Each result was averaged for triple independent experiments. Statistical significance was presented as * p < 0.05, ** p <
0.01, *** p < 0.001, ns: no significance
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we examined the starvation-induced autophagic vesicles
in each cell line with the EGFP-LC3 reporter assay. It
was indicated in Fig. 5f and g that the infection with 1
MOI LV-Beclin1 promoted more autophagic vesicles
than the LV-Con infection in either PC12 (Synwt) or
PC12 (Synmt) cells (p < 0.05). Thus, we also confirmed
the positive regulation by Beclin1 on the starvation-
induced autophagy in PC12 cells.
Discussion
HMGB1, as a cytokine-like factor [33], is increasingly rec-
ognized as a novel autophagy regulator via interfering with
the PIK3C3 complex [34]. Nucleus-to-cytosol translocated
HMGB1 competitively binds to Beclin1 and subsequently
induces autophagy [35]. However, α-synuclein has been
shown to impair the autophagy [36, 37]. In particular, α-
synuclein could bind to both cytoplasmic and nuclear
Fig. 4 Western blot analysis of autophagy-associated markers in the PC12 (Synwt) or the PC12 (Synmt) cells, which were treated with HMGB1.
a: Western blotting assay of LC3-I, LC3-II, Atg 7 and mTOR in the PC12 (Synwt) cells which were treated with 0, 0.2, 0.5 or 1 μg/mL HMGB1,
under starvation for 24 hours; b: Ratio of LC3-II to LC3-I in the starvation-treated PC12 (Synwt) cells with HMGB1 treatment; c and d: Relative level of
Atg 7 (c) and mTOR (d) levels to β-actin in the PC12 (Synwt) cells with HMGB1 treatment; e: Western blotting assay of LC3-I, LC3-II, Atg 7 and mTOR in
the PC12 (Synmt) cells which were treated with 0, 0.2, 0.5 or 1 μg/mL HMGB1, under starvation for 24 hours; f: Ratio of LC3-II to LC3-I in the
starvation-treated PC12 (Synmt) cells with HMGB1 treatment; g and h: Relative level of Atg 7 (g) and mTOR (h) levels to β-actin in the PC12
(Synmt) cells with HMGB1 treatment. Data was averaged for triple independent results, ns: no significance
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HMGB1, block HMGB1-Beclin1 binding, whereas to
strengthen the Beclin1-BcL2 binding [31], and thus to in-
hibit autophagy. And such inhibition could be restored by
the Beclin 1 overexpression. In the present study, we
found that the overexpression of either WT or MT α-
synuclein markedly reduced the cytoplasmic levels of both
Fig. 5 Beclin1 upregulation reduces α-synuclein accumulation and ameliorates the α-synuclein-inhibited autophagy in PC12 (Synwt) and PC12
(Synmt) cells. a: Western blot analysis of Beclin1 and α-synuclein in the PC12 (Synwt) and PC12 (Synmt) cells which were infected with 1 multiplicity
of infection (MOI) pLenti-Beclin1 (LV-Beclin1) or pLenti-Con (LV-Con) under starvation for 12 or 24 hours; b and c: Ratio of Beclin1 to β-actin in PC12
(Synwt) (b) and PC12 (Synmt) (c) cells which were infected with LV-Beclin1 or with LV-Con virus; d and e: Ratio of α-synuclein to β-actin in PC12 (Synwt)
(b) and PC12 (Synmt) (c) cells which were infected with LV-Beclin1 or with LV-Con virus; f and g: Imaging (f) and counting (g) of EGFP-positive
autophagic vesicles in the starvation-treated PC12 (Synwt) or PC12 (Synmt), which were infected with LV-Beclin1 or with LV-Con virus. Each result was
averaged for triple independent experiments. Statistical significance was presented as * p < 0.05, ** p < 0.01, *** p < 0.001, ns: no significance
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HMGB1 and Beclin1 in PC12 cells, implying the reduced
HMGB1 and Beclin1 might contribute to the α-synuclein-
mediated autophagy inhibition in PC12 cells.
Impaired autophagy has been indicated to correlate
with the α-synuclein aggregation and neurodegeneration
in PD [38–41]; and the stimulated autophagy could re-
duce the accumulation of α-synuclein in cells and in
mouse brain [12, 42], and could even rescue midbrain
dopamine neurons from α-synuclein toxicity [43]. On
the other side, α-synuclein has been shown to impair au-
tophagy [36, 37]. The overexpression of either WT or
MT α-synuclein inhibits autophagy in pheochromocy-
toma PC12 cells [31], impairs neurite outgrowth of pri-
mary midbrain neurons, affects neurite branching [44].
In this study, we reconfirmed such autophagy inhibition
by α-synuclein overexpression in PC12 cells, the overex-
pression of wild-type or mutant-type α-synuclein signifi-
cantly downregulated the starvation-induced autophagy
via inhibiting the mTOR/Atg 7 signaling. Therefore, we
also confirmed the autophagy inhibition by the overex-
pressed α-synuclein in PC12 cells. And it implies that
the reduced HMGB1 and Beclin1 might contribute to
the reduced autopahgy in the α-synuclein-overexpressed
PC12 cells.
HMGB1 is also known as the high-mobility group
protein 1 (HMG-1). As a chromatin-associated nuclear
protein, it is a critical regulator of autophagy. And the
pharmacological inhibition of HMGB1 cytoplasmic trans-
location limits starvation-induced autophagy. Moreover,
only endogenous HMGB1 has been indicated to regulate
the Bcl-2-Beclin1 binding, via the direct interact with
Beclin 1 [34, 35], and thus regulating the convergence of
autophagy and apoptosis, via interacting with anti-
apoptotic Bcl-2-like proteins [45]. Our study confirmed
that either endogenous HMGB1 or Beclin 1 overexpres-
sion promoted the α-synuclein degradation in PC12
cells. Moreover, the overexpressed HMGB1 or Beclin 1
markedly ameliorated the α-synuclein-mediated autoph-
agy reduction in the α-synuclein-overexpressed (either
WT or MT) PC12 cells, implying the promotion by
HMGB1 to the α-synuclein degradation might be
autophagy-dependent. And such amelioration might be
dependent on the HMGB1-Beclin1 interaction.
Interesting, our results indicated that the extracellular
HMGB1 exerted no regulatory role on the starvation-
induced autophagy, posing no influence on the levels of
mTOR and Atg 7 in both PC12 (Synwt) and PC12
(Synmt) cells. HMGB1 is a secretary cytokine from acti-
vated macrophages and monocytes [46] to mediate in-
flammation [33], via binding to receptor for advanced
glycation endproducts (RAGE) [47] or to toll-like recep-
tor (TLR) [48]. However, the present study confirmed
that the promotion by HMGB1 was not RAGE- or TLR-
dependent. In addition, the gain-of-function strategy also
confirmed the promotion to the α-synuclein degradation
and the autophagy induction by Beclin1 overexpression
in PC12 cells. Taken together, we speculated that endogen-
ous HMGB1 and Beclin1 might promote the autophagic
degradation of α-synuclein. Therefore, the endogenous
HMGB1 and Beclin1 exerts protective role in the cells
against the α-synuclein accumulation.
Conclusion
In summary, α-synuclein with wild-type or mutant-type
inhibited autophagy in PC12 cells via inhibiting the
HMGB1 and Beclin1. On the other side, the cytosolic
promotion to HMGB1 or to Beclin1 up-regulates the au-
tophagic degradation of α-synuclein via increasing the
autophagy in PC12 cells. Therefore, the endogenous
HMGB1 and Beclin1 present protective role in the cells
against the α-synuclein accumulation.
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